CastleKnight Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$562K Hold
66,300
0.01% 442
2026
Q1
$361K Hold
66,300
0.01% 423
2025
Q4
$464K Sell
66,300
-198,300
-75% -$1.55M 0.01% 314
2025
Q3
$2.05M Buy
264,600
+32,800
+14% +$256K 0.04% 228
2025
Q2
$2.02M Hold
231,800
0.06% 212
2025
Q1
$1.85M Buy
231,800
+22,000
+10% +$223K 0.07% 164
2024
Q4
$1.91M Buy
209,800
+67,100
+47% +$648K 0.06% 177
2024
Q3
$1.31M Buy
142,700
+37,500
+36% +$310K 0.05% 191
2024
Q2
$1.03M Buy
+105,200
New +$1.28M 0.05% 213

Other funds holding TDOC

CastleKnight Management's TDOC Position: Q2 2026 in Review

CastleKnight Management held its Teladoc Health (TDOC) position steady in Q2 2026 at 66,300 shares worth $562K. The position accounts for 0.01% of the portfolio, ranked #442.

CastleKnight Management first reported a position in TDOC in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.05M in Q3 2025. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • CastleKnight Management held 66,300 shares of Teladoc Health worth $562K as of Q2 2026.
  • CastleKnight Management left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up 0.01% of CastleKnight Management's portfolio in Q2 2026, its #442 holding.
  • CastleKnight Management first reported a position in Teladoc Health in Q2 2024 and has held it in 9 quarters since.
  • CastleKnight Management's Teladoc Health position peaked at $2.05M in Q3 2025.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on CastleKnight Management's 13F filing for Q2 2026, filed 14 Aug 2026.